Sheshadri, A., Saliba, R., Patel, B., Ahmed, T., Bueno, L. C., Arain, M. H., . . . Alousi, A. M. (2020). Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients. Bone Marrow Transplant.
Dyfyniad Arddull ChicagoSheshadri, Ajay, et al. "Azithromycin May Increase Hematologic Relapse Rates in Matched Unrelated Donor Hematopoietic Cell Transplant Recipients Who Receive Anti-thymocyte Globulin, but Not in Most Other Recipients." Bone Marrow Transplant 2020.
Dyfyniad MLASheshadri, Ajay, et al. "Azithromycin May Increase Hematologic Relapse Rates in Matched Unrelated Donor Hematopoietic Cell Transplant Recipients Who Receive Anti-thymocyte Globulin, but Not in Most Other Recipients." Bone Marrow Transplant 2020.